Kieran O'Kane, Chief Commercial Officer at BIODESIX INC (BDSX), sold 465 shares at $1.60 ($740) on 2024-08-09, disclosed to the SEC on 2024-08-12.
Open-market sale of $740 BDSX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 345 | $552 | 74.6% |
| 2 | $1.57 | 120 | $188 | 25.4% |
| Total | $1.59 avg | 465 | $740 | 100% |
| Filing → |
| BDSX | SELL | 2026-01-20 | $2K | — | Filing → |
| BDSX | SELL | 2025-11-13 | $191 | — | Filing → |
| BDSX | SELL | 2025-08-14 | $200 | — | Filing → |